May 17, 2022
STERLING, Va. — Euclid Vision Corp. has named Zohra Fadli, PhD, as the Global Head of Research and Development and Clinical Affairs. Dr. Fadli brings decades of experience in medical device technology and vision care to her new role at Euclid, including an extensive history in delivering breakthrough ophthalmic contact lenses.
For close to 20 years, Dr. Fadli held global leadership roles in Johnson and Johnson’s medical technology divisions. She led the Johnson and Johnson Vision Care Light Management Portfolio, launching a first-of-its-kind light adaptive photochromic contact lens, which was named by Time Magazine as one of the best inventions in 2018.
Dr. Fadli also led Johnson and Johnson’s core contact lens business, including sphere daily disposable, reusable, and lens care, where she played an integral role in setting up the innovation, pipeline, and development of Johnson and Johnson’s first monthly silicone hydrogel reusable contact lens. Dr. Fadli expanded her responsibilities to lead Johnson and Johnson Vision Care Specialty Growth Business, including the Myopia Progression platform, Presbyopia platform, and Beauty platforms. She also pioneered Johnson and Johnson Vision Care’s global evidence generation strategy, which aimed to generate best-in-class clinical and technical scientific evidence in support of new product innovations. Dr. Fadli also led the R&D Strategy and Operations team for Johnson and Johnson’s orthopedic surgical franchise. Dr. Fadli holds a PhD in Medical Bioengineering from Université Paris 13, France.
“We are excited to bring Dr. Fadli on board at this pivotal time in Euclid’s evolution,” said Joseph Boorady, Euclid President and CEO. “Having market leading technologies in two of the fastest growing specialty contact lens markets — OrthoK and scleral lenses — positions Euclid to best serve our customers today, and having Dr. Fadli heading up R&D positions us to anticipate and satisfy patient needs tomorrow and in the coming years.”